BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 22054881)

  • 1. Molecular biology of lung cancer: clinical implications.
    Larsen JE; Minna JD
    Clin Chest Med; 2011 Dec; 32(4):703-40. PubMed ID: 22054881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.
    Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R
    Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer epigenetics and genetics.
    Risch A; Plass C
    Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic changes in lung carcinoma and their clinical implications.
    Wen J; Fu J; Zhang W; Guo M
    Mod Pathol; 2011 Jul; 24(7):932-43. PubMed ID: 21423157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma.
    Ileana EE; Wistuba II; Izzo JG
    Cancer J; 2015; 21(5):413-24. PubMed ID: 26389767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating DNA and lung cancer.
    Xue X; Zhu YM; Woll PJ
    Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
    Massion PP; Carbone DP
    Respir Res; 2003; 4(1):12. PubMed ID: 14641911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic characteristics of lung cancer--useful as real' tumor markers?
    Fleischhacker M; Beinert T; Possinger K
    Lung Cancer; 1999 Jul; 25(1):7-24. PubMed ID: 10466858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and lung cancers: from pathogenesis to clinical implications.
    Qi J; Mu D
    Front Med; 2012 Jun; 6(2):134-55. PubMed ID: 22528868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential biomarkers for the early detection of lung cancer.
    Gruidl ME; Shaw Wright GL
    J Thorac Imaging; 2000 Jan; 15(1):13-20. PubMed ID: 10634657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological considerations in lung cancer.
    Almand B; Carbone DP
    Cancer Treat Res; 2001; 105():1-30. PubMed ID: 11224984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in Lung Cancer.
    de Sousa VML; Carvalho L
    Pathobiology; 2018; 85(1-2):96-107. PubMed ID: 29635240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.
    Punturieri A; Szabo E; Croxton TL; Shapiro SD; Dubinett SM
    J Natl Cancer Inst; 2009 Apr; 101(8):554-9. PubMed ID: 19351920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of lung cancer and potential translational applications.
    Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
    Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
    Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
    Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.